Literature DB >> 32262855

Tailoring the biological response of mesoporous bioactive materials.

N Gómez-Cerezo1, I Izquierdo-Barba, D Arcos, M Vallet-Regí.   

Abstract

Mesoporous bioactive glasses (MBGs) in the SiO2-CaO-P2O5 system have been prepared using different non-ionic structure directing agents (SDA): Brij58, F68, P123 and F127. For the first time, the bioactive response of MBGs can be tailored with the kind of SDA incorporated. This is because, in addition to the textural properties, we can use the SDA to tailor the local atomic environment within the MBG struts. These features lead to differences in the in vitro bioactive behaviour of MBGs. Among the different SDAs used in this work, the triblock copolymer F68 leads to MBGs that exhibit the fastest bioactivity and the fastest differentiation induction from a pre-osteoblast to an osteoblast phenotype. These results are explained in terms of a highly ordered mesoporous structure, more free calcium cations acting as silica network modifiers and small mesopores that avoid the formation of CaP nuclei within pores, which could obstruct the ionic exchange with the surrounding fluids.

Entities:  

Year:  2015        PMID: 32262855     DOI: 10.1039/c5tb00268k

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  3 in total

1.  Mesoporous bioactive glass composition effects on degradation and bioactivity.

Authors:  M Schumacher; P Habibovic; S van Rijt
Journal:  Bioact Mater       Date:  2020-12-21

2.  Strontium-releasing mesoporous bioactive glasses with anti-adhesive zwitterionic surface as advanced biomaterials for bone tissue regeneration.

Authors:  Carlotta Pontremoli; Isabel Izquierdo-Barba; Giorgia Montalbano; María Vallet-Regí; Chiara Vitale-Brovarone; Sonia Fiorilli
Journal:  J Colloid Interface Sci       Date:  2019-12-14       Impact factor: 8.128

Review 3.  Mesoporous Bioglasses Enriched with Bioactive Agents for Bone Repair, with a Special Highlight of María Vallet-Regí's Contribution.

Authors:  Antonio J Salinas; Pedro Esbrit
Journal:  Pharmaceutics       Date:  2022-01-15       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.